Jeffery F. Miller
Founder at Pylum Biosciences, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David W. Martin | M | 82 |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | - |
James L. Knighton | M | 70 |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | - |
Kevin Cameron | M | 64 |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | - |
Linda M. Rosenstock | M | 73 |
David Geffen School of Medicine
| 24 years |
Ian A. Cook | M | 64 |
David Geffen School of Medicine
| 14 years |
Linda Liau | M | 57 |
David Geffen School of Medicine
| - |
Andrew Woo | M | 61 |
David Geffen School of Medicine
| - |
Heather Dale Jones | M | - |
David Geffen School of Medicine
| - |
Jonathan Corren | M | - |
David Geffen School of Medicine
| - |
Chun Kit Ho | M | 47 |
David Geffen School of Medicine
| - |
Fran Klemens | M | - |
Pylum Biosciences, Inc.
Pylum Biosciences, Inc. BiotechnologyHealth Technology Pylum Biosciences, Inc. develops and patents an Avidocin platform technology capable of generating bactericidal protein complexes targeting specific bacterial pathogens. Its platform modifies to generate new protein complexes to kill emerging strains as their genome sequences become available. The company was founded by James L. Knighton, Kevin Cameron, Jeffery F. Miller and David W. Martin and is headquartered in South San Francisco, CA. | - |
Cathleen Bairey-Merz | M | 68 |
David Geffen School of Medicine
| - |
Richard David | M | 64 |
David Geffen School of Medicine
| - |
Perry Shieh | M | - |
David Geffen School of Medicine
| - |
Anna M. Wu | M | - |
David Geffen School of Medicine
| - |
Dennis Joseph Slamon | M | 75 |
David Geffen School of Medicine
| - |
Frederick C. Beddingfield | M | 59 |
David Geffen School of Medicine
| 21 years |
Arie Belldegrun | M | 74 |
David Geffen School of Medicine
| 24 years |
Robert E. Reiter | M | - |
David Geffen School of Medicine
| - |
David L. Hill | M | 73 |
David Geffen School of Medicine
| - |
Owen Witte | M | 74 |
David Geffen School of Medicine
| - |
Yutaka Niihara | M | 65 |
David Geffen School of Medicine
| - |
Robert Figlin | M | - |
David Geffen School of Medicine
| - |
Scott Weingarten | M | - |
David Geffen School of Medicine
| - |
Julia Gouw | F | 64 |
David Geffen School of Medicine
| - |
Allen Nissenson | M | 77 |
David Geffen School of Medicine
| 47 years |
Matthew Freeby | M | - |
David Geffen School of Medicine
| - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 27 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jeffery F. Miller
- Personal Network